Literature DB >> 18274453

Expression changes caused by the peptide semax in the intracellular signal pathway genes in rat hippocamp.

T Yu Agapova1, Ya V Agniullin, D N Silachev, M I Shadrina, P A Slominsky, S I Shram, S A Limborskaya, N F Myasoedov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18274453     DOI: 10.1134/s1607672907060129

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  12 in total

1.  [Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone].

Authors:  N I Kurysheva; A A Shpak; E E Ioĭleva; L I Galanter; N D Nagornova; N Iu Shubina; N N Shlyshalova
Journal:  Vestn Oftalmol       Date:  2001 Jul-Aug

2.  Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using pair-wise correlations.

Authors:  Michael W Pfaffl; Ales Tichopad; Christian Prgomet; Tanja P Neuvians
Journal:  Biotechnol Lett       Date:  2004-03       Impact factor: 2.461

3.  Degradation of the ACTH(4-10) analog Semax in the presence of rat basal forebrain cell cultures and plasma membranes.

Authors:  Yu A Zolotarev; O V Dolotov; L S Inozemtseva; A K Dadayan; E M Dorokhova; L A Andreeva; L Yu Alfeeva; I A Grivennikov; N F Myasoedov
Journal:  Amino Acids       Date:  2006-05-26       Impact factor: 3.520

4.  Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

Authors:  Oleg V Dolotov; Ekaterina A Karpenko; Lyudmila S Inozemtseva; Tamara S Seredenina; Natalia G Levitskaya; Joanna Rozyczka; Elena V Dubynina; Ekaterina V Novosadova; Lyudmila A Andreeva; Lyudmila Yu Alfeeva; Andrey A Kamensky; Igor A Grivennikov; Nikolay F Myasoedov; Jürgen Engele
Journal:  Brain Res       Date:  2006-09-22       Impact factor: 3.252

5.  Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Authors:  Kirill O Eremin; Vladimir S Kudrin; Pirjo Saransaari; Simo S Oja; Igor A Grivennikov; Nikolay F Myasoedov; Kirill S Rayevsky
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 6.  Vital elements of the Wnt-Frizzled signaling pathway in the nervous system.

Authors:  Faqi Li; Zhao Zhong Chong; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2005-10       Impact factor: 1.990

7.  [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].

Authors:  I P Asmarin; V N Nezavibat'ko; N F Miasoedov; A A Kamenskiĭ; I A Grivennikov; M A Ponomareva-Stepnaia; L A Andreeva; A Ia Kaplan; V B Koshelev; T V Riasina
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1997 Mar-Apr       Impact factor: 0.437

8.  Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog.

Authors:  M I Shadrina; O V Dolotov; I A Grivennikov; P A Slominsky; L A Andreeva; L S Inozemtseva; S A Limborska; N F Myasoedov
Journal:  Neurosci Lett       Date:  2001-08-03       Impact factor: 3.046

9.  Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10.

Authors:  T Y Agapova; Y V Agniullin; M I Shadrina; S I Shram; P A Slominsky; S A Lymborska; N F Myasoedov
Journal:  Neurosci Lett       Date:  2007-02-20       Impact factor: 3.046

10.  [Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration].

Authors:  K V Shevchenko; I Iu Nagaev; L Iu Alfeeva; L A Andreeva; A A Kamenskiĭ; N G Levitskaia; V P Shevchenko; I A Grivennikov; N F Miasoedov
Journal:  Bioorg Khim       Date:  2006 Jan-Feb
View more
  1 in total

1.  The effect of semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia.

Authors:  V G Dmitrieva; L V Dergunova; O V Povarova; V I Skvortsova; S A Limborskaya; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2008 Sep-Oct       Impact factor: 0.788

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.